DPP4 and stroke disorder: The inclusion in our network analysis of the AMPLITUDE-O and EMPEROR-P data have modified the conclusions of the most recent similar analysis [15] indicating that SGLT-2 inhibitors increased the risk of stroke as compared with GLP-1RA and that GLP-1RA are superior to DPP-4 inhibitors as for nonfatal MI.